Sec. 11.06.04.04. Obligations of Opioid Treatment Centers

A. After obtaining approval as required by Regulation .03 of this chapter, an opioid treatment center shall submit an agreement signed by an authorized individual of the opioid treatment center on the form required by the Administration, agreeing to the obligations listed in this regulation and other obligations required by the Administration.

B. The opioid treatment center shall maintain accurate, timely, and complete records of all transactions related to fare products acquired and distributed under Regulation .03 of this chapter.

C. The opioid treatment center shall provide periodic reports of its inventory of fare products to the Administration.

D. The opioid treatment center may only issue fare products to eligible individuals.

E. The opioid treatment center may charge a fee for fare products no more than the rate charged by the Administration for the fare product.

F. The opioid treatment center shall immediately report the loss or suspension of its license by the Department of Health.

G. If an opioid treatment center violates the agreement or obligations stated in this regulation, the Administration may suspend its approval to issue fare products for a period of 1 year or longer, depending on the severity of the offense.

H. Within 15 calendar days after receipt of a written determination, an opioid treatment center may appeal the denial or termination of approval to the Office of Administrative Hearings for a final decision in accordance with COMAR 28.02.01.

I. An aggrieved party may seek judicial review of any final administrative decision under this chapter in accordance with the provisions of the Administrative Procedure Act, State Government Article, §10-222, Annotated Code of Maryland.